All News

    An Oncology Nurse Who Learns From Patients in Clinical Trials

    April 29th 2022

    An interview with Margaret Campbell, B.S.N, RN, the winner of the 2022 Extraordinary Healer® award.

    A Quiet Hero for Patients With Cancer

    April 29th 2022

    Not only have Margaret Campbell's, own patients benefited from her dedication, but so many patients in the United States and around the world have access to better treatments due to her contributions.

    As the World Moves on, I’m Reminded at How Much Time Was Lost to Cancer

    April 29th 2022

    Throughout my cancer experience, I’ve relied heavily on friends and family for support. But as they are moving on and starting families of their own, I realized how much time I’ve lost to cancer.

    Osteosarcoma Survivor With Leg Amputation Models for Popular Fashion Brands, Oasis Guitarist Receives Cancer Diagnosis and More

    April 29th 2022

    From an osteosarcoma survivor modeling inclusivity in the fashion world to rock guitarist Paul “Bonehead” Arthurs being diagnosed with cancer, here’s what’s happening in the cancer space this week.

    Educated Patient® Kidney Cancer Summit IO/TKI Therapies Presentation: April 9, 2022

    April 29th 2022

    Watch Dr. Jeff Yorio, from Texas Oncology, discuss treatment with the combination of immunotherapy and tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.

    Enhertu Granted Breakthrough Therapy Designation for Unresectable/Metastatic Breast Cancer Treatment

    April 28th 2022

    After Enhertu showed promising clinical trial results, the Food and Drug Administration agreed to speed up the development and review of the drug for certain patients with unresectable or metastatic breast cancer.

    Peripheral Neuropathy Is ‘Underestimated’ in Patients Undergoing Cancer Treatment

    April 28th 2022

    Chemotherapy-induced peripheral neuropathy is a common side effect of patients undergoing cancer treatment, though many patients are not fully informed about the condition before their therapy starts.

    While I Appreciate the Concern, Think Before Speaking to Cancer Survivors

    April 28th 2022

    Well-meaning comments can come off as bothersome — or even hurtful — to me as I navigate cancer.

    Educated Patient® Kidney Cancer Summit IO/IO Therapies Presentation: April 9, 2022

    April 28th 2022

    Watch Dr. Saby George, from Roswell Park Comprehensive Cancer Center, discuss treatment with the combination of immunotherapies, during the CURE Educated Patient Kidney Cancer Summit.

    Margaret Campbell, B.S.N, RN, Wins CURE®’s 2022 Extraordinary Healer® Award

    April 28th 2022

    For the first time in three years, CURE® welcomed 500 attendees in person and hundreds more virtually to honor the 2022 Extraordinary Healer® award recipient.

    Launching of Early-Phase Trial May Mark a ‘Major Milestone’ for Improving Gastric and Pancreatic Cancer Treatment

    April 27th 2022

    The first patient was dosed in the CLAUDIO-01 trial, analyzing SOTO102 in patients with certain types of gastric and pancreatic cancers.

    10 Things That Helped Me Show Up for Chemo As My Best Self

    April 27th 2022

    From my “game-day uniform” to a playlist that made me feel ready to seize the day, here’s what helped me prepare for my days in cancer treatment.

    During the Pre-Cancer Days, My Intuition Pushed Me in the Right Direction

    April 27th 2022

    Before being diagnosed with neuroendocrine cancer, I started to live a healthier life and took notice of some concerning symptoms.

    Imfinzi May Be Better in a Combination for Advanced Lung Cancer

    April 27th 2022

    Imfinzi alone is the standard of care in this patient population, however two combinations may have better outcomes.

    Educated Patient® Kidney Cancer Summit Panel on Communicating With Providers About Immunotherapy/TKI Combo Treatment: April 9, 2022

    April 27th 2022

    Watch Dr. Thomas Hutson, Louise Gunter and Meryl Uranga discuss communicating with a care team about treatment with immunotherapy combined with tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.

    Long-Term Axi-Cel Data ‘May Be Suggestive of a Cure’ in Patients With Large B-Cell Lymphoma

    April 26th 2022

    The majority of patients with relapsed/refractory large B-cell lymphoma were alive between four and five years after being treated with axi-cel.

    FDA Agrees to Speed Up Review of Ofra-Vec for Platinum-Resistant Ovarian Cancer

    April 26th 2022

    The FDA granted a Fast Track designation to ofra-vec plus paclitaxel for the treatment of patients with platinum-resistant ovarian cancer.

    Until Sugar Is Definitely Linked to ‘Feeding Cancer,’ We’ll Celebrate Birthdays With Cake

    April 26th 2022

    If there was a certain diet that could prevent my daughter from going through the perils of chemotherapy, she’d do it in a heartbeat. But science doesn’t back the sugar-feeds-cancer myth.

    Depicting the Grind of Cancer Through Art: How Deconstructing the Disease Led a Mother to Own Her Diagnosis

    April 26th 2022

    Alex Mallonee has found it inspiring to depict his mother’s journey with breast cancer through art, and hopes others affected by cancer will feel the same.

    Educated Patient® Kidney Cancer Summit Panel on Side Effects from Immunotherapy/TKI Combo Treatment: April 9, 2022

    April 26th 2022

    Watch Dr. Thomas Hutson, Louise Gunter and Meryl Uranga discuss side effects and dose reductions after treatment with immunotherapy combined with tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.

    Patient Receives Treatment With Novel Drug in First-in-Human Trial Assessing its Safety and Efficacy in Brain and Lung Cancer

    April 25th 2022

    The drug, known as BDTX-1535, is being investigated in patients with glioblastoma that harbors EGFR alterations and non-small cell lung cancer that harbors EGFR mutations of intrinsic or acquired resistance and disease that has failed standard treatment.

    Better Data Needed to Approve Future PI3K Inhibitors for Blood Cancers, FDA Panel Recommends

    April 25th 2022

    A panel of experts on the FDA’s Oncologic Drugs Advisory Committee voted that all future approvals of PI3K inhibitors to treat blood cancer be backed by randomized clinical trial data.

    Combating a Cancer Treatment Side Effect Turned Me Into a 'Calcium Junkie'

    April 25th 2022

    After my breast cancer metastasized to my lungs, I was put on a PARP inhibitor, which caused an unexpected side effect that, unfortunately, happens like clockwork.

    Drug Commonly Used to Treat Rare Lung Condition May Improve Survival in Patients With Bladder Cancer

    April 25th 2022

    Treatment with a combination of Ofev and chemotherapy was shown to have a survival benefit in a group of patients with bladder cancer.

    Educated Patient® Kidney Cancer Summit Panel on Immunotherapy/TKI Combo Treatment: April 9, 2022

    April 25th 2022

    Watch Dr. Thomas Hutson, Louise Gunter and Meryl Uranga discuss the treatment of combining immunotherapy with tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.

    Educated Patient® Kidney Cancer Summit Frontline Therapy Panel: April 9, 2022

    April 24th 2022

    Watch Dr. Thomas Hutson, Dr. Jose Karam, Dr, Naomi Haas, and Kiran Kehoe answer questions about frontline therapy during the CURE Educated Patient Kidney Cancer Summit.

    Educated Patient® Kidney Cancer Summit Adjuvant Therapy Options Presentation: April 9, 2022

    April 23rd 2022

    Watch Dr. Naomi Haas, from Abramson Cancer Center, discuss adjuvant therapy options, during the CURE Educated Patient Kidney Cancer Summit.

    First Patient Treated in Study to Determine Tolerability, Dosing of Investigational Drug in Certain Solid Tumors

    April 22nd 2022

    Once a recommended dose of the drug is determined, the study investigators will review the efficacy and safety associated with this treatment across a variety of patients with bladder and liver cancer, as well other solid tumors.

    More Research Efforts Needed to Ensure Kidney Cancer Treatments ‘Get Smarter’ to Limit Side Effects, Expert Says

    April 22nd 2022

    An expert discusses the side effects patients with kidney cancer may experience from immunotherapy and tyrosine kinase inhibitor treatment, and how more research is needed in to ensure patients experience less side effects.

    Things I Wish I Knew Before Breast Cancer

    April 22nd 2022

    There are so many things I wish I’d known before being diagnosed with breast cancer, but if I’d known them all in advance, I wouldn’t have learned many valuable lessons.

    NEXT PAGE
    PREVIOUS PAGE